Cargando…

Impact of COVID‐19 lockdown on routine oncology versus emergency care at a high volume cancer centre

BACKGROUND: We investigated the influence of population‐wide COVID‐19 lockdown measures implemented on 16, March 2020 on routine and emergency care of cancer outpatients at a tertiary care cancer centre in Vienna, Austria. METHODS: We compared the number/visits of cancer outpatients receiving oncolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minichsdorfer, Christoph, Jeryczynski, Georg, Krall, Christoph, Achhorner, Alina Magdalena, Caraan, Ariane, Pasalic, Sabina, Reininger, Katharina, Wagner, Christina, Bartsch, Rupert, Preusser, Matthias, Laggner, Anton, Raderer, Markus, Fuereder, Thorsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209914/ https://www.ncbi.nlm.nih.gov/pubmed/34085717 http://dx.doi.org/10.1111/eci.13623

Ejemplares similares

PD-L1 Expression on Tumor Cells Is Associated With a Poor Outcome in a Cohort of Caucasian Nasopharyngeal Carcinoma Patients
por: Minichsdorfer, Christoph, et al.
Publicado: (2019)

Circumnavigating the challenges of COVID-19 in oncology
por: Fuereder, Thorsten, et al.
Publicado: (2020)

The European Society for Medical Oncology 'Magnitude of Clinical Benefit Scale' field-tested in infrequent tumour entities: an extended analysis of its feasibility at the Medical University of Vienna
por: Kiesewetter, Barbara, et al.
Publicado: (2017)

Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy
por: Minichsdorfer, Christoph, et al.
Publicado: (2022)

Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field
por: Marhold, Maximilian, et al.
Publicado: (2020)

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna
por: Kiesewetter, Barbara, et al.
Publicado: (2016)

Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer
por: Fuchs, Hannah, et al.
Publicado: (2018)

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
por: Starzer, Angelika Martina, et al.
Publicado: (2022)

Risk factors for Clostridium difficile infection in hemato-oncological patients: A case control study in 144 patients
por: Fuereder, Thorsten, et al.
Publicado: (2016)

Targeted Therapy Recommendations for Therapy Refractory Solid Tumors—Data from the Real-World Precision Medicine Platform MONDTI
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic
por: Fuereder, Thorsten, et al.
Publicado: (2020)

Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study
por: Mair, Maximilian J., et al.
Publicado: (2022)

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
por: Bartsch, Rupert, et al.
Publicado: (2022)

Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial
por: Minichsdorfer, Christoph, et al.
Publicado: (2020)

Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology
por: Prager, Gerald W., et al.
Publicado: (2019)

Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial
por: Mair, Maximilian J., et al.
Publicado: (2023)

Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI
por: Kieler, Markus, et al.
Publicado: (2019)

European Society for Medical Oncology 2020
por: Bartsch, Rupert
Publicado: (2021)

Statins induce apoptosis in human melanoma cells via multiple pathways
por: Minichsdorfer, Christoph, et al.
Publicado: (2008)

Cytokine signalling in human melanoma cells determines susceptability to statin-induced apoptosis
por: Minichsdorfer, Christoph, et al.
Publicado: (2009)

Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18
por: Minichsdorfer, C., et al.
Publicado: (2022)

CECOG educational illustrations: the blood–brain barrier and its relevance for targeted cancer therapies and immuno-oncology
por: Preusser, Matthias, et al.
Publicado: (2017)

Simvastatin targets the IL-6 signalling cascade in human melanoma cells
por: Wasinger, Christine, et al.
Publicado: (2011)

IL-6-mediated migration of human metastatic melanoma cells is reduced by simvastatin treatment
por: Wasinger, Christine, et al.
Publicado: (2012)

Maintaining routine parasite prevention in lockdown
por: Wright, Ian
Publicado: (2020)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study
por: Moik, Florian, et al.
Publicado: (2020)

SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic: Conclusions for crisis response at a high-volume oncology center
por: Berger, Julia M., et al.
Publicado: (2021)

Delineation of cell death mechanisms induced by synergistic effects of statins and erlotinib in non-small cell lung cancer cell (NSCLC) lines
por: Otahal, Alexander, et al.
Publicado: (2020)

AVAiLABLE NIS – AVASTIN® in lung cancer treatment in routine oncology practice in Germany
por: Zahn, Mark-Oliver, et al.
Publicado: (2019)

CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion
por: Preusser, Matthias, et al.
Publicado: (2018)

Metal drugs become targeted
por: Fuereder, Thorsten, et al.
Publicado: (2017)

Selective serotonin reuptake inhibitor-induced cell death: in search of a mechanism
por: Glöckel, Christina, et al.
Publicado: (2010)

Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer
por: Wolff, Ladislaia, et al.
Publicado: (2023)

Tocilizumab unmasks a stage-dependent interleukin-6 component in statin-induced apoptosis of metastatic melanoma cells
por: Minichsdorfer, Christoph, et al.
Publicado: (2015)

Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron
por: Mair, Maximilian J., et al.
Publicado: (2022)

Impact of COVID-19 lockdown on routine immunisation in Karachi, Pakistan
por: Chandir, Subhash, et al.
Publicado: (2020)

Recent developments and translational aspects in targeted therapy for metastatic breast cancer
por: Marhold, Maximilian, et al.
Publicado: (2016)

Chemotherapy-associated oral microbiome changes in breast cancer patients
por: Klymiuk, Ingeborg, et al.
Publicado: (2022)

Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers
por: Berghoff, Anna S, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_udtkd00liuav3abrevpmtng5m8